Type 1 Diabetes

Home/Type 1 Diabetes

First comes knowledge

2019-03-23T18:38:20+00:00Advanced Type 2, Hypoglycaemia Assessment, Patient education, Type 1 Diabetes|

By: Belinda Childs |Date: 21 March 2019| Categories: Patient Education, Advanced Type 2, Type 1 Diabetes, Hypoglycaemia Assessment
Reducing the risk of hypoglycaemia is a multifaceted challenge. For starters, health providers need to understand which behaviours raise and decrease the risk, so they can communicate this information to individuals with diabetes and the people who care for them.

Dead in bed syndrome

2019-02-01T01:53:30+00:00Severe hypoglycaemia, Type 1 Diabetes|

By: Simon Heller | Date: 30 October 2018| Categories: Dead in bed syndrome, Nocturnal Hypoglycaemia, Severe Hypoglycaemia, Type 1 Diabetes
Dead in bed syndrome understandably strikes terror in the hearts of people with type 1 diabetes and their families. Clinicians, for their part, may find it difficult to discuss the syndrome with patients and thus avoid the topic. Fortunately, the syndrome is rare enough that the key message to patients is reassurance.

Invisible Damage – When hypoglycaemia goes silent

2018-07-04T14:43:46+00:00Asymptomatic hypoglycaemia, Hypoglycaemic events, Impaired Awareness, Type 1 Diabetes|

By: Ulrik Pedersen-Bjergaard |Date: Thursday 31 May 2018| Categories: Hypoglycaemia, Driving performance, Insulin-treated, Impaired Awareness
Asymptomatic hypoglycaemia (AH) is where clinical and biochemical realities diverge.

Severe Hypoglycaemia in Children: A Shifting Landscape

2018-07-04T14:43:46+00:00Diabetes in Children, Hypoglycaemia, Type 1 Diabetes|

By: Tim Jones, MD, DCH, FRACP|Date: Friday 26 January 2018| Categories: Diabetes in Children, Hypoglycaemia, Type 1 Diabetes
Many clinicians perceive the risk of severe hypoglycaemia as firmly tethered to the level of glucose control: the tighter the control, the greater the risk. This perception has its roots in the historical association between A1C and hypoglycaemia risk, established in several studies. As a frequently cited example, the DCCT trial found a 3-fold increased risk of severe hypoglycaemia in patients randomized to the intensive management arm of the study.